240 related articles for article (PubMed ID: 25217655)
41. Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity.
Al-Abd AM; Al-Abbasi FA; Asaad GF; Abdel-Naim AB
Eur J Pharmacol; 2013 Oct; 718(1-3):361-9. PubMed ID: 24021537
[TBL] [Abstract][Full Text] [Related]
42. Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Jin Z; Zhang J; Zhi H; Hong B; Zhang S; Guo H; Li L
J Cardiol; 2013 Aug; 62(2):110-6. PubMed ID: 23731918
[TBL] [Abstract][Full Text] [Related]
43. Pilot study of vascular health in survivors of osteosarcoma.
Mulrooney DA; Ness KK; Huang S; Solovey A; Hebbel RP; Neaton JD; Clohisy DR; Kelly AS; Neglia JP
Pediatr Blood Cancer; 2013 Oct; 60(10):1703-8. PubMed ID: 23720361
[TBL] [Abstract][Full Text] [Related]
44. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.
Zerra P; Cochran TR; Franco VI; Lipshultz SE
Expert Opin Pharmacother; 2013 Aug; 14(11):1497-513. PubMed ID: 23705955
[TBL] [Abstract][Full Text] [Related]
45. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.
Dolinsky VW; Rogan KJ; Sung MM; Zordoky BN; Haykowsky MJ; Young ME; Jones LW; Dyck JR
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E243-53. PubMed ID: 23695218
[TBL] [Abstract][Full Text] [Related]
46. Activity of dexrazoxane and amifostine against late cardiotoxicity induced by the combination of doxorubicin and cyclophosphamide in vivo.
Bjelogrlic SK; Lukic ST; Djuricic SM
Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):228-38. PubMed ID: 23692343
[TBL] [Abstract][Full Text] [Related]
47. Exercise mitigates cardiac doxorubicin accumulation and preserves function in the rat.
Jensen BT; Lien CY; Hydock DS; Schneider CM; Hayward R
J Cardiovasc Pharmacol; 2013 Sep; 62(3):263-9. PubMed ID: 23644988
[TBL] [Abstract][Full Text] [Related]
48. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
[TBL] [Abstract][Full Text] [Related]
49. FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction.
Sontag DP; Wang J; Kardami E; Cattini PA
Cardiovasc Toxicol; 2013 Sep; 13(3):244-53. PubMed ID: 23430353
[TBL] [Abstract][Full Text] [Related]
50. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
Piegari E; De Angelis A; Cappetta D; Russo R; Esposito G; Costantino S; Graiani G; Frati C; Prezioso L; Berrino L; Urbanek K; Quaini F; Rossi F
Basic Res Cardiol; 2013 Mar; 108(2):334. PubMed ID: 23411815
[TBL] [Abstract][Full Text] [Related]
51. Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer.
Jenei Z; Bárdi E; Magyar MT; Horváth A; Paragh G; Kiss C
Pathol Oncol Res; 2013 Jul; 19(3):375-83. PubMed ID: 23242567
[TBL] [Abstract][Full Text] [Related]
52. Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis.
Rafiyath SM; Rasul M; Lee B; Wei G; Lamba G; Liu D
Exp Hematol Oncol; 2012 Apr; 1(1):10. PubMed ID: 23210520
[TBL] [Abstract][Full Text] [Related]
53. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.
Lipshultz SE; Miller TL; Lipsitz SR; Neuberg DS; Dahlberg SE; Colan SD; Silverman LB; Henkel JM; Franco VI; Cushman LL; Asselin BL; Clavell LA; Athale U; Michon B; Laverdière C; Schorin MA; Larsen E; Usmani N; Sallan SE;
Pediatrics; 2012 Dec; 130(6):1003-11. PubMed ID: 23166343
[TBL] [Abstract][Full Text] [Related]
54. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study.
Seicean S; Seicean A; Plana JC; Budd GT; Marwick TH
J Am Coll Cardiol; 2012 Dec; 60(23):2384-90. PubMed ID: 23141499
[TBL] [Abstract][Full Text] [Related]
55. Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Zhang S; Liu X; Bawa-Khalfe T; Lu LS; Lyu YL; Liu LF; Yeh ET
Nat Med; 2012 Nov; 18(11):1639-42. PubMed ID: 23104132
[TBL] [Abstract][Full Text] [Related]
56. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.
Ruggiero A; De Rosa G; Rizzo D; Leo A; Maurizi P; De Nisco A; Vendittelli F; Zuppi C; Mordente A; Riccardi R
Int J Clin Oncol; 2013 Oct; 18(5):927-33. PubMed ID: 22911020
[TBL] [Abstract][Full Text] [Related]
57. Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines.
Yağci-Küpeli B; Varan A; Yorgun H; Kaya B; Büyükpamukçu M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):368-74. PubMed ID: 22898185
[TBL] [Abstract][Full Text] [Related]
58. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.
Harake D; Franco VI; Henkel JM; Miller TL; Lipshultz SE
Future Cardiol; 2012 Jul; 8(4):647-70. PubMed ID: 22871201
[TBL] [Abstract][Full Text] [Related]
59. Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.
Hadi N; Yousif NG; Al-amran FG; Huntei NK; Mohammad BI; Ali SJ
BMC Cardiovasc Disord; 2012 Aug; 12():63. PubMed ID: 22867422
[TBL] [Abstract][Full Text] [Related]
60. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.
Armstrong GT; Plana JC; Zhang N; Srivastava D; Green DM; Ness KK; Daniel Donovan F; Metzger ML; Arevalo A; Durand JB; Joshi V; Hudson MM; Robison LL; Flamm SD
J Clin Oncol; 2012 Aug; 30(23):2876-84. PubMed ID: 22802310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
